The independent source for health policy research, polling, and news.
881 - 900 of 3,873 Results
A push is underway to create a National Patient Safety Board modeled after the National Transportation Safety Board, an independent federal agency that investigates plane crashes and other transportation disasters. But unlike the NTSB, some patient safety advocates say, the current proposal is toothless and wouldn’t provide transparency about the nation’s hospitals.
When KFF Health News’ “What the Health?” podcast launched in 2017, Republicans in Washington were engaged in an (ultimately unsuccessful) campaign to “repeal and replace” the Affordable Care Act. The next six years would see a pandemic, increasingly unaffordable care, and a health care workforce experiencing unprecedented burnout. In the podcast’s 300th episode, host and chief Washington correspondent Julie Rovner explores the past and possible future of the U.S. health care system with three prominent “big thinkers” in health policy: Ezekiel Emanuel of the University of Pennsylvania, Jeff Goldsmith of Health Futures, and Farzad Mostashari of Aledade.
KFF Health News senior correspondent Aneri Pattani appeared on PBS NewsHour to discuss the ruling surrounding drugmaker Purdue Pharma's role in the opioid crisis and her reporting into the ongoing distribution of opioid settlement funds.
The federal government’s arcane process for medical coding is influencing which reconstructive surgery options are available, creating anxiety for breast cancer patients.
The Department of Health and Human Services is tasked with monitoring denials both by Obamacare health plans and those offered through employers and insurers. As insurers’ denials become more common, they sometimes defy not just medical standards of care but sheer logic. Why hasn’t the agency fulfilled its assignment?
Family planning clinics are getting caught between state abortion bans and a federal requirement to refer patients for abortion care on request.
As hospitals squeeze Democratic leaders in Sacramento for more money, health care finance experts and former state officials warn against falling for the industry’s fear tactics. They point to healthy profits and a recession-era financing scheme that allows rich hospitals to take tax money from poorer ones.
Doctors say they are reluctant to practice in abortion-banned states, where making the best decision for a patient could run afoul of the law. Even former President Donald Trump’s surgeon general is concerned about the repercussions for women’s health, writes KFF Health News’ chief Washington correspondent, Julie Rovner.
Industry analysts are skeptical that Federal Trade Commission Chair Lina Khan can win her first fight against a drug industry merger. It will be reviewed by a judge appointed by then-President Donald Trump.
A three-judge appeals court panel heard testimony this week about revoking the FDA’s 22-year-old approval of a key pill used in medication abortion and miscarriage management. The judges all have track records of siding with abortion foes. Meanwhile, as the standoff over raising the federal debt ceiling continues in Washington, a major sticking point is whether to impose work requirements on recipients of Medicaid coverage. Victoria Knight of Axios, Rachel Roubein of The Washington Post, and Sandhya Raman of CQ Roll Call join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more.
Given a dire shortage of human behavioral health providers in the U.S., it may prove tempting for insurers to offer up apps and chatbots to meet the federal mental health parity requirement. But artificial intelligence, by definition fake, can’t master the empathic flow between patient and doctor that’s central to therapy.
The profound and painful loss — 80 million years of life, compared with the white population — is a call to action to improve the health of Black Americans, especially infants, mothers, and seniors, researchers say.
In his new book, “Faster Cures,” the former “junk bond king,” now a philanthropist, promotes business principles as catalysts for medical breakthroughs.
Nearly 30 states have active or proposed laws authorizing independent hospital police forces. Groups representing nurses and hospitals say the laws address the daily realities of patients who become aggressive or agitated. But critics worry about unintended consequences.
A federally funded program in remote New Mexico has helped hundreds of pregnant mothers stay healthy, but it’s running out of time and money despite a growing national maternity care crisis. The four-year, nearly $3 million grant has provided telehealth, coordinated care, and social services to mothers in need.
The lawyer for an emergency physicians group says its lawsuit against Envision Healthcare should be allowed to proceed even though the company has filed for Chapter 11 protection.
Giant corporations like Microsoft and Google, plus many startups, are eyeing health care profits from programs based on artificial intelligence.
The public health emergency declaration for covid-19 ends May 11, ushering in major changes in how Americans can access and pay for the vaccines, treatments, and tests particular to the culprit coronavirus. But not everyone will experience the same changes, creating a confusing patchwork of coverage — not unlike health coverage for other diseases. Meanwhile, outside advisers to the FDA formally recommended allowing a birth control pill to be sold without a prescription. If the FDA follows the recommendation, it would represent the first over-the-counter form of hormonal contraception. Margot Sanger-Katz of The New York Times, Tami Luhby of CNN, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KFF Health News’ Julie Rovner to discuss these issues and more. Plus for “extra credit” the panelists suggest health policy stories they read this week they think you should read, too.
What should you do when your search for an in-network mental health care provider comes up empty? Abigail Burman has some expertise to share.
Drugmakers, pharmacies, and physicians blame pharmacy benefit managers for high drug prices. Congress is finally on board, too, but will it matter?
© 2026 KFF